Essex LLC’s Titan Medical Inc. Ordinary Shares TMDI Stock Holding History

Essex LLC’s Portfolio TMDI Stock Details TMDI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,857,640	Closed	-$1.89M	–	163
2023 Q1	$1.89M	Hold	2,857,640	–	–	0.57%	55
2022 Q4	$1.89M	Buy	2,857,640 +493,422	+21%	+$260K	0.57%	55
2022 Q3	$1.06M	Buy	2,364,218 +359,581	+18%	+$186K	0.35%	72
2022 Q2	$1.08M	Buy	2,004,637 +370,394	+23%	+$181K	0.33%	75
2022 Q1	$922K	Sell	1,634,243 -19,940	-1%	-$11.6K	0.25%	87
2021 Q4	$1.09M	Buy	1,654,183 +169,600	+11%	+$191K	0.29%	78
2021 Q3	$2.27M	Buy	+1,484,583	New	+$2.41M	0.63%	50

Other funds holding TMDI

FHC

First Heartland Consultants Lake St. Louis, Missouri $1.55B AUM 20.5% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Essex LLC's TMDI Position: Q2 2023 in Review

Essex LLC sold out of Titan Medical Inc. Ordinary Shares (TMDI) in Q2 2023, closing a stake of 2,857,640 shares — an estimated $1.89M sold.

Essex LLC first reported a position in TMDI in Q3 2021 and held it in 7 quarters. The position peaked at $2.27M in Q3 2021. 5 funds tracked by Wall St. Rank hold TMDI as of Q2 2023.

Essex LLC reported no remaining Titan Medical Inc. Ordinary Shares position as of Q2 2023 after selling out during the quarter.
Essex LLC sold 2,857,640 Titan Medical Inc. Ordinary Shares shares in Q2 2023, an estimated $1.89M.
Essex LLC first reported a position in Titan Medical Inc. Ordinary Shares in Q3 2021 and held it in 7 quarters.
Essex LLC's Titan Medical Inc. Ordinary Shares position peaked at $2.27M in Q3 2021.
5 funds tracked by Wall St. Rank held Titan Medical Inc. Ordinary Shares as of Q2 2023.

Based on Essex LLC's 13F filing for Q2 2023, filed 31 Jul 2023.